RUNX2 as a novel biomarker for early identification of patients progressing to advanced-stage mycosis fungoides

IntroductionThe majority of patients with mycosis fungoides (MF) have an indolent disease course, but a substantial fraction (20-30%) of patients progress to advanced stages – usually with a grave prognosis. Early differentiation between indolent and aggressive types of MF is important for the choic...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Maria Danielsen, Thomas Emmanuel, Morten Muhlig Nielsen, Lise Maria Lindahl, Maria Gluud, Niels Ødum, Line Raaby, Torben Steiniche, Lars Iversen, Rikke Bech, Terkild Brink Buus, Claus Johansen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-10-01
Subjects:	mycosis fungoides digital spatial profiling biomarkers RNA profiling spatial transcriptomics
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1421443/full